Huya Bioscience China

Huya Bioscience China is owned by Huya Bioscience International. Huya Bioscience International has a direct presence in 3 countries.

View the org chart displaying its 5 main executives

Most searched biographies at Huya Bioscience China

• Reagan Poon, Associate Director, Hong Kong
• Xinan Chen, Executive Vice President, Strategic Development
• Yung-Chih Wang, Senior Vice President, Corporate Development

Create your alert
to follow the executive moves at Huya Bioscience China.

Huya Bioscience International has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Huya Bioscience China

Social media about Huya Bioscience China

• Huya Bioscience China on Wikipedia, Google News & Yahoo Finance
• Huya Bioscience China on LinkedIn, Twitter & YouTube

Contact by email its executives including Rulun Zhou

Call Huya Bioscience China at +86 215...

View the org chart

Register to receive your alert

Report an error